Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
The STEP trials for semaglutide 2.4 mg (Wegovy) showed: Average weight loss of approximately 15% of body weight over 68 weeks One-third of participants lost 20% or more of body weight Significant reductions in waist circumference, blood pressure, and cardiovascular risk markers The SURMOUNT trials for tirzepatide (Zepbound) showed even more impressive results: Average weight loss of 20-25% at the highest dose (15 mg) over 72 weeks More than half of participants lost 20% or more of body weight Significant improvements in type 2 diabetes markers, blood pressure, and lipid profiles The head-to-head comparison is clear
Keep it separate from food, and note the date you first opened any multi-dose vial
It may cause some drowsiness, but usually not as much as Benadryl
Pharmacol Rev 76:9781008
GLP-1 Mini Troches are prescription treatments that mimic a natural hormone involved in appetite and blood-sugar regulation
What are Units Injected
:format(webp))
